Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
25 April, 2024 13:55 IST
Nomura stays neutral on PNB; cuts price target to Rs 160
Source: IRIS | 11 May, 2015, 12.35PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

Nomura Financial Advisory and Securities has maintained 'Neutral' rating on Punjab National Bank (PNB) with revised target price of Rs 160 from Rs 200 with current market price (CMP) of Rs 146 in its report.

Commenting on the investment rationale, Nomura said, ''4QFY15 was a rather significant miss with highest-ever stress accretion (15% annualised) leading to a PBT loss of Rs 6.3 billion. Total impairment at Rs 150 billion was 2x of expectations and highlights PNB's weak underwriting vs peers. While PNB attempted to front-end part of the stress through restructuring borderline cases, with 10% restructured book, relapse risk remains highest.

PNB reported slippage of  INR74bn (INR55bn in 3QFY15) and restructuring of Rs 78 billion (Rs 27 billion in 3QFY15) leading to 2x increase in impairment levels from an already weak asset quality base. Impairments were high from power and metals but still do not include names like Bhushan/Essar where exposure levels are higher. It seems that PNB has front ended some recognition to take benefit of the sunset in restructuring and impairment levels would likely come off in 1QFY16, but with 10% standard restructured book now, relapse risk remains the highest.

We cut FY16-17F EPS by 15% and our TP to Rs 160 (0.8x FY17F book). The TP cut was driven by the 8% cut in book value and reducing multiple to 0.9x to 0.8x FY17F book. While our FY15-17F earnings at 30% CAGR looks large it just gets ROEs back to 12% from 8% currently and hence we believe 0.8x FY16F book is fair multiple. Relapse risk remains the highest and hence we continue to remain cautious.''

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.

 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer